DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney research as well as a multitude of specialist therapeutic populations, has hired four people to expand its latest clinical research facility in Denver, Colorado.
The new team members are: Dr Christopher Galloway, medical director; Chad Jaeger, senior director of clinical operations; Amy Denvir, director of operations, Denver; and Michael Kreuter, director of data management.
Dr Galloway has more than 12 years’ experience in medical practice, while Jaeger’s involvement in the early clinical research industry spans the past 16 years in both clinical and commercial operations. His last position prior to joining DCR was senior account executive for Covance’s early clinical pharmacology units.
As the director of operations, Denvir will use more than 20 years of early phase CRO industry experience to launch the new Denver facility and ensure Good Clinical Practice (GCP) is maintained. Denvir formerly worked for Metroplex Clinical Research Center, Covance, Radiant Research and MDS Pharma Services in a variety of operational leadership roles.
Kreuter has held various senior level data management director positions for the past 16 years at several organisations including Sanofi Pasteur, M3 Clinical Research and SDI.
DCR’s new facility encompasses 35,000ft2 and will be connected to St Anthony Hospital in Lakewood, Colorado. It will support high-risk studies and will have an expanded ability to support both patient and healthy volunteer Phase I clinical studies.